BRAIDWELL LP

Position in DYN — Dyne Therapeutics, Inc.

CIK 1920938 STAMFORD, CT

Position in DYN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$20,468,691

-$10,025,932 QoQ

Shares Held

921,598

-45.2% QoQ

Ownership

0.494%

of shares outstanding

% of Portfolio

0.79%

of 13F equity value

Holder Rank

#43

of 245 holders

Holding Since

Dec 2022

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

BRAIDWELL LP holds $1,531,675,908 across 50 Biotechnology names. DYN ranks #28 (1.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CAI	Caris Life Sciences, Inc.	8,256,032	$147,122,490
2	EWTX	Edgewise Therapeutics, Inc.	1,996,965	$81,136,687
3	SYRE	Spyre Therapeutics, Inc.	879,467	$78,079,080
4	KOD	Kodiak Sciences Inc.	1,787,318	$69,633,909
5	XENE	Xenon Pharmaceuticals Inc.	1,131,452	$68,294,442
6	GLUE	Monte Rosa Therapeutics, Inc.	2,451,562	$59,327,800
7	DNTH	Dianthus Therapeutics, Inc. /DE/	594,562	$57,957,903
8	GENB	Generate Biomedicines, Inc.	3,283,844	$55,398,448

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$20,468,691	921,598	-45.2%	Shares	Sole	2026-08-14
2026-03-31	$30,494,623	1,681,998	+13.8%	Shares	Sole	2026-05-15
2025-12-31	$28,916,115	1,478,329	-45.9%	Shares	Sole	2026-02-17
2025-09-30	$34,540,584	2,730,481	-16.6%	Shares	Sole	2025-11-14
2025-06-30	$31,162,282	3,273,349	-9.6%	Shares	Sole	2025-08-14
2025-03-31	$37,879,258	3,621,344	+431.6%	Shares	Sole	2025-05-15
2024-12-31	$16,048,647	681,182	-9.9%	Shares	Sole	2025-02-14
2023-12-31	$10,052,286	755,811	-58.5%	Shares	Sole	2024-02-14
2023-09-30	$16,324,869	1,821,972	+32.2%	Shares	Sole	2023-11-14
2023-06-30	$15,501,060	1,377,872	0.0%	Shares	Sole	2023-08-14
2023-03-31	$15,873,085	1,377,872	+82.9%	Shares	Sole	2023-05-15
2022-12-31	$8,728,950	753,145	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.